Abstract
Purpose
Hysterectomy for benign conditions can be combined with bilateral salpingectomy to prevent re-intervention for malignant or benign fallopian tube pathologies. The objective of this study was to evaluate the benefit of prophylactic bilateral salpingectomy (PBS) in standard hysterectomy in premenopausal women.
Methods
This retrospective cohort study included all premenopausal patients at our institution who underwent laparoscopically assisted vaginal hysterectomy (LAVH) without oophorectomy for benign pathologies between 2001 and 2007 [PBS group (LAVH + PBS), 2006–2007; non-PBS group (LAVH without PBS), 2001–2005]. Electronic and paper-based files as well as questionnaire responses were analyzed. In 2010, a survey on patients of a non-BRCA background with and without PBS was requested to complete a standardized questionnaire. Data were analyzed for differences between both subgroups regarding surgical outcome and adnexal pathologies as reported in the postoperative follow-up.
Results
Surgical outcomes of 540 patients (PBS: 127; non-PBS: 413) revealed no difference between groups. No preneoplastic or malignant lesions were diagnosed in the fallopian tubes. Follow-up (non-PBS 92 months, PBS 55 months; p < 0.01) responses from 295 (54.6 %) patients showed a higher incidence of benign adnexal pathologies in the non-PBS group (26.9 vs. 13.9 %; p = 0.02). The rate of LAVH-related surgical re-intervention was higher in the non-PBS group (12.56 vs. 4.16 %; p = 0.04). No malignant neoplasm was reported in the cohort.
Conclusions
PBS did not increase the complication rate and reduced the incidence of adnexal pathologies requiring surgical re-intervention. Prospective trials should clarify the impact of PBS on cancer mortality.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Callahan MJ, Crum CP et al (2007) Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol 25(25):3985–3990
Childers JM, Surwit EA (1992) Combined laparoscopic and vaginal surgery for the management of two cases of stage I endometrial cancer. Gynecol Oncol 45(1):46–51
Chornokur G, Amankwah EK, Schildkraut JM, Phelan CM (2013) Global ovarian cancer health disparities. Gynecol Oncol 129(1):258–264
Cibula D, Widschwendter M et al (2011) Tubal ligation and the risk of ovarian cancer: review and meta-analysis. Hum Reprod Update 17(1):55–67
Crum CP, Drapkin R et al (2007) The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol 19(1):3–9
Dar P, Sachs GS et al (2000) Ovarian function before and after salpingectomy in artificial reproductive technology patients. Hum Reprod 15(1):142–144
Devendra K, Tay SK (2002) Laparoscopically-assisted vaginal hysterectomy (LAVH)—an alternative to abdominal hysterectomy. Singapore Med J 43(3):138–142
Dietl J, Wischhusen J et al (2011) The post-reproductive Fallopian tube: better removed? Hum Reprod 26(11):2918–2924
Dindo D, Demartines N et al (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213
Ghezzi F, Cromi A et al (2009) Infectious morbidity after total laparoscopic hysterectomy: does concomitant salpingectomy make a difference? BJOG 116(4):589–593
Gill SE, Mills BB (2013) Physician opinions regarding elective bilateral salpingectomy with hysterectomy and for sterilization. J Minim Invasive Gynecol 20(4):517–521
Guldberg R, Lidegaard O et al (2013) Salpingectomy as standard at hysterectomy? A Danish cohort study, 1977–2010. BMJ Open 3(6). doi:10.1136/bmjopen-2013-002845
Jarboe EA, Miron A et al (2009) Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance. Int J Gynecol Pathol 28(4):308–315
Kindelberger DW, Lee Y et al (2007) Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 31(2):161–169
Medeiros F, Muto MG et al (2006) The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 30(2):230–236
Mingels MJ, van Ham MA et al (2013) Mullerian precursor lesions in serous ovarian cancer patients: using the SEE-Fim and SEE-End protocol. Mod Pathol. doi:10.1038/modpathol.2013.212
Morelli M, Venturella R et al (2013) Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere. Gynecol Oncol 129(3):448–451
Morse AN, Hammer RA, et al (2002) Does hysterectomy without adnexectomy in patients with prior tubal interruption increase the risk of subsequent hydrosalpinx? Am J Obstet Gynecol 187(6):1483–1485; discussion 1485–1486
Morse AN, Schroeder CB et al (2006) The risk of hydrosalpinx formation and adnexectomy following tubal ligation and subsequent hysterectomy: a historical cohort study. Am J Obstet Gynecol 194(5):1273–1276
Nahas E, Pontes A et al (2003) Inhibin B and ovarian function after total abdominal hysterectomy in women of reproductive age. Gynecol Endocrinol 17(2):125–131
Owens WD, Felts JA et al (1978) ASA physical status classifications: a study of consistency of ratings. Anesthesiology 49(4):239–243
Piek JM, van Diest PJ et al (2001) Tubal ligation and risk of ovarian cancer. Lancet 358(9284):844
Przybycin CG, Kurman RJ et al (2010) Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol 34(10):1407–1416
Radosa JC, Radosa MP et al (2013) Five minutes of extended assisted ventilation with an open umbilical trocar valve significantly reduces postoperative abdominal and shoulder pain in patients undergoing laparoscopic hysterectomy. Eur J Obstet Gynecol Reprod Biol 171(1):122–127
Repasy I, Lendvai V et al (2009) Effect of the removal of the Fallopian tube during hysterectomy on ovarian survival: the orphan ovary syndrome. Eur J Obstet Gynecol Reprod Biol 144(1):64–67
Rezvani M, Shaaban AM (2011) Fallopian tube disease in the nonpregnant patient. Radiographics 31(2):527–548
Runnebaum IB, Tong XW et al (1994) p53 mutant His175 identified in a newly established fallopian tube carcinoma cell line secreting interleukin 6. FEBS Lett 353(1):29–32
Sezik M, Ozkaya O et al (2007) Total salpingectomy during abdominal hysterectomy: effects on ovarian reserve and ovarian stromal blood flow. J Obstet Gynaecol Res 33(6):863–869
Singla A (2007) An unusual case of torsion hydrosalpinx after hysterectomy: a case report. Aust N Z J Obstet Gynaecol 47(3):256–257
Statistisches Bundesamt (2011) Gesundheit. Grunddaten der Krankenhäuser. Fachserie 12:6.1.1
Strandell A, Lindhard A et al (2001) Prophylactic salpingectomy does not impair the ovarian response in IVF treatment. Hum Reprod 16(6):1135–1139
Timor-Tritsch IE, Monteagudo A et al (2010) Three-dimensional ultrasound inversion rendering technique facilitates the diagnosis of hydrosalpinx. J Clin Ultrasound 38(7):372–376
Whiteman MK, Hillis SD et al (2008) Inpatient hysterectomy surveillance in the United States, 2000–2004. Am J Obstet Gynecol 198(1):34e31–34e37
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
J. Vorwergk and M. P. Radosa have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Vorwergk, J., Radosa, M.P., Nicolaus, K. et al. Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate. J Cancer Res Clin Oncol 140, 859–865 (2014). https://doi.org/10.1007/s00432-014-1622-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-014-1622-6